Duchenne Muscular Dystrophy : Methods and Protocols /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Humana,
2018.
|
| Edición: | 1st ed. 2018. |
| Colección: | Methods in Molecular Biology,
1687 |
| Materias: |
Tabla de Contenidos:
- An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy.- Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy
- Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies
- Characterization of the Inflammatory Response in Dystrophic Muscle Using Flow Cytometry
- Imaging Analysis of the Neuromuscular Junction in Dystrophic Muscle
- System Biology Approach: Gene Network Analysis for Muscular Dystrophy
- Proteomic Profiling of the Dystrophin-Deficient Brain
- Probing the Pathogenesis of Duchenne Muscular Dystrophy Using Mouse Models
- Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy
- Designing Effective Antisense Oligonucleotides for Exon Skipping
- Identification of Splicing Factors Involved in DMD Exon Skipping Events Using an In Vitro RNA Binding Assay
- The Use of Antisense Oligonucleotides for the Treatment of Duchenne Muscular Dystrophy
- PMO Delivery System Using Bubble Liposomes and Ultrasound Exposure for Duchenne Muscular Dystrophy Treatment
- Proton Nuclear Magnetic Resonance (1H NMR) Spectroscopy-Based Analysis of Lipid Components in Serum / Plasma of Patients with Duchenne Muscular Dystrophy (DMD)
- Test of Anti-Fibrotic Drugs in a Cellular Model of Fibrosis Based on Muscle-Derived Fibroblasts from Duchenne Muscular Dystrophy Patients
- Flow Cytometry-Defined CD49d Expression in Circulating T-Lymphocytes is a Biomarker for Disease Progression in Duchenne Muscular Dystrophy
- Advanced Methods to Study the Cross-Talk Between Fibro-Adipogenic Progenitors and Muscle Stem Cells
- AAV6 Vector Production and Purification for Muscle Gene Therapy
- From gRNA Identification to the Restoration of Dystrophin Expression: A Dystrophin Gene Correction Strategy for Duchenne Muscular Dystrophy Mutations Using the CRISPR-Induced Deletion Method.